FARMINGDALE, N.Y., March 1, 2011 /PRNewswire/ -- Misonix, Inc. (Nasdaq: MSON), a medical device company that designs, manufactures, and markets innovative, therapeutic, ultrasonic products worldwide for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications, announced today that it will present at the ROTH Capital 23rd Annual Growth Stock Conference on Tuesday, March 15, 2011 at the Ritz Carlton Hotel, Dana Point, CA. Richard Zaremba, Senior Vice President and Chief Financial Officer, will address the conference at 10:00 AM Pacific time to discuss the Company's business strategy and historical financial performance.
Misonix, Inc. designs, manufactures and markets therapeutic ultrasonic medical devices and laboratory and scientific equipment. Misonix's therapeutic ultrasonic platform is the basis for several innovative medical technologies. Addressing a combined market estimated to be in excess of $3 billion annually; Misonix's proprietary ultrasonic medical devices are used for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications. Additional information is available on the Company's Web site at www.misonix.com.
Investor Relations Contact:
Kevin McGrath, Cameron Associates, Inc.
SOURCE Misonix, Inc.